local
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
By ABC at KSTP 5 Eyewitness News (ABC)
· June 29, 2026
· 5 min read
WASHINGTON (AP) — When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.
The Food and Drug Administration on Monday ...
Key takeaway Previous FDA panels on the topic have been composed of academics and researchers.
Why this matters in The Minneapolis
Minneapolis residents who follow wellness trends or have athletes in their families may be interested in the upcoming FDA meeting on peptide drugs. The city's numerous health and wellness clinics, as well as its thriving athletic community, may be impacted by the FDA's decision on the safety and effectiveness of these substances. Some Minneapolis-based businesses may even be selling or promoting these peptides, often labeled as "for research use only," which could put consumers at risk. The fact that the new FDA panel includes doctors and pharmacists with financial ties to the peptide industry raises concerns about the potential for biased decision-making. As the FDA reconsiders its stance on these unproven chemicals, Minneapolis consumers should be aware of the potential risks and lack of evidence behind the claims made by peptide sellers. The city's health professionals and consumers will be watching the outcome of this meeting closely.
About this story
Original reporting by KSTP 5 Eyewitness News (ABC) . The Minneapolis surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KSTP 5 Eyewitness News (ABC) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: June 29, 2026 ·
Source: KSTP 5 Eyewitness News (ABC) ·
Reading time: 5 min
Get more The Minneapolis stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? WASHINGTON (AP) — When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.
The Food and Drug Administration on Monday ...
When was this published? This article was first published on June 29, 2026 by KSTP 5 Eyewitness News (ABC) and curated for The Minneapolis readers.
Who reported this story? This story was reported by ABC at KSTP 5 Eyewitness News (ABC). To learn more about how The Minneapolis selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Minneapolis, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter